The Strategic Approach to HL7/FHIR Project Planning Healthcare integration projects are notorious for exceeding budgets and timelines. Industry surveys consistently show that the majority of
Navigating HIPAA Compliance in the Age of Data Analytics Healthcare organizations face a constant tension between leveraging patient data for insights and maintaining strict privacy
BREAKING Through integration complexity barriers Healthcare organizations often find themselves stuck in analysis paralysis when tackling HL7/FHIR integration projects. The complexity of healthcare data standards
Caristix launches new “Live” applications to assist customers in their integration journey Posted May 11, 2021, by the Caristix Team Over the decade, Caristix has
Hello HL7 community, we’ve decided to give the old HL7-Definition reference website its well-deserved retirement. We’re now proud to introduce the new and improved HL7-Definition
Hello HL7 community, we’ve decided to give the old HL7-Definition reference website its well-deserved retirement. We’re now proud to introduce the new and improved HL7-Definition
DIAGRAM EDITOR There is a new module, called Diagram Editor. This module replaces the current Interface View and includes many requested features such as: Create
Caristix release 3.2 is a broad release of additional features through the range of Caristix products from Workgroup through the individual HL7 modules, Cloak, Conformance,
In the design of Meaningful use, C-CDA – especially CCD – was supposed to solve the pressing issues in healthcare concerning interoperability and data
This release is focused on test automation within the Caristix platform. We’ve developed significant new features to accelerate test creation and test execution. This will
NORTH AMERICA: +1 (877)-872-0027
WORLD: 1-418-872-4000
EMAIL: info@caristix.com
ASIA-PACIFIC
DENIS CANTIN
T: +61418441388
denis.cantin@caristix.com
NORTH AMERICA & EUROPE
JEAN-LUC MORIN
T: 418 872-4000
jeanluc.morin@caristix.com
HL7® / FHIR® are a registered trademarks of Health Level Seven International. The use of this trademark does not constitute an endorsement by HL7.
